| GC33430-50mg |
|
65358-18-1 |
2’-Deoxypseudoisocytidine
|
0 |
C9H13N3O4 |
|
|
|
| GC33430-25mg |
|
65358-18-1 |
2’-Deoxypseudoisocytidine
|
0 |
C9H13N3O4 |
|
|
|
| GC33430-10mg |
|
65358-18-1 |
2’-Deoxypseudoisocytidine
|
0 |
C9H13N3O4 |
|
|
|
| GC33430-5mg |
|
65358-18-1 |
2’-Deoxypseudoisocytidine
|
0 |
C9H13N3O4 |
|
|
|
| GC33430-1mg |
|
65358-18-1 |
2’-Deoxypseudoisocytidine
|
0 |
C9H13N3O4 |
|
|
|
| GC33430-10mM(1mLinDMSO) |
|
65358-18-1 |
2’-Deoxypseudoisocytidine
|
0 |
C9H13N3O4 |
|
|
|
| GC33429-25mg |
|
245443-52-1 |
Protease-Activated Receptor-4
|
0 |
C33H46N8O7 |
|
|
|
| GC33429-10mg |
|
245443-52-1 |
Protease-Activated Receptor-4
|
0 |
C33H46N8O7 |
|
|
|
| GC33429-5mg |
|
245443-52-1 |
Protease-Activated Receptor-4
|
0 |
C33H46N8O7 |
|
|
|
| GC33428-50mg |
|
344940-63-2 |
|
0 |
C25H19N3O |
|
|
|
| GC33428-10mg |
|
344940-63-2 |
|
0 |
C25H19N3O |
|
|
|
| GC33428-5mg |
|
344940-63-2 |
|
0 |
C25H19N3O |
|
|
|
| GC33427-5g |
|
298-96-4 |
|
0 |
C19H15ClN4 |
|
|
|
| GC33426-100mg |
|
84573-16-0 |
Rocaglamide (Rocaglamide A)
|
0 |
C29H31NO7 |
|
|
|
| GC33426-50mg |
|
84573-16-0 |
Rocaglamide (Rocaglamide A)
|
0 |
C29H31NO7 |
|
|
|
| GC33426-25mg |
|
84573-16-0 |
Rocaglamide (Rocaglamide A)
|
0 |
C29H31NO7 |
|
|
|
| GC33426-10mg |
|
84573-16-0 |
Rocaglamide (Rocaglamide A)
|
0 |
C29H31NO7 |
|
|
|
| GC33426-5mg |
|
84573-16-0 |
Rocaglamide (Rocaglamide A)
|
0 |
C29H31NO7 |
|
|
|
| GC33426-1mg |
|
84573-16-0 |
Rocaglamide (Rocaglamide A)
|
0 |
C29H31NO7 |
|
|
|
| GC33426-500μg |
|
84573-16-0 |
Rocaglamide (Rocaglamide A)
|
0 |
C29H31NO7 |
|
|
|
